The chaperone protein RIC-3 is known to modulate the functional surface expression of cationconducting pentameric ligand-gated ion channels. Previously we have demonstrated that the intracellular domain of serotonin channels mediates this effect. Here we provide experimental evidence for a 24-amino acid long segment within the 115-amino acid long intracellular domain as a determinant for RIC-3 interaction. Recently it was found experimentally that the identified segment contains an alpha helix that has been observed or predicted to be present in other cation-conducting channels. The present work provides novel insights into protein-protein interactions that are likely also relevant for other cation-conducting members of this large ion channel family that includes nACh and 5-HT3 receptors.
Introduction
Serotonin receptors type 3 (5-HT 3 ), like the nicotinic acetylcholine (nACh), -aminobutyric acid type A (GABA A ), and glycine (Gly) receptors, are members of the pentameric ligand-gated ion channel (pLGIC) superfamily. Ion channels of this Cys-loop superfamily are homo-or heteropentamers. 5-HT 3 receptors are composed of five identified subunits (A-E) and are involved in excitatory neurotransmission [1] . These receptors are abundant in the central and peripheral nervous systems (CNS, PNS) and are found pre-and postsynaptically [2] . Among all subunits of 5-HT 3 receptors, the 5-HT 3A subunit is widely distributed in CNS, PNS, and internal organs and is also found in non-neural cells and tissues across the human body [3] . While the 5-HT 3B subunit is less abundant, the mRNA of this subunit has been detected in several regions of the human brain, intestines and in the kidney [4] . The mRNAs of the remaining 5-HT 3 subunits (C-E) have been found in PNS and CNS, organs and extraneuronal cells [5, 6] .
Currently, these receptors are mainly targeted in emesis treatment in patients undergoing chemotherapy or suffering from irritable bowel syndrome [5, 7] . Recent studies have shown potential correlations between 5-HT 3 receptor activity and several neurological disorders such as anxiety, psychosis, nociception and cognitive function [8] [9] [10] . Some studies also suggest that 5-HT3 receptors play a role in bipolar disorder and schizophrenia [11, 12] .
Each subunit of a pLGIC pentamer consists of three domains, namely extracellular domain (ECD), transmembrane domain (TMD) with four membrane spanning helices (M1-M4), and intracellular domain (ICD, only in eukaryotic pLGICs) [13] . The assembly, functional maturation and membrane trafficking of pLIGIC subunits are modulated by different chaperone proteins depending on their subtype. The protein Resistance to Inhibitors of Cholinesterase (RIC-3) is known as a modulator of nAChRs as well as 5-HT 3A Rs [14, 15] . RIC-3, a protein originally identified in the worm Caenorhabditis elegans, was shown to be necessary for proper functional expression of homomeric nAChR α 7 and to enhance the surface expression of 5-HT 3A R in HEK cells [16] [17] [18] . In contrast, co-expression of RIC-3 with heteromeric nAChR α 3β4 and α 4β2 as well as 5-HT 3A R in Xenopus laevis oocytes inhibits the functional maturation of these receptors [15, 16, 18, 19] . The discrepancy in modulatory effects of RIC-3 on different pLGICs might stem from host cell variations and/or species differences of studied receptors [18, 20] . Previously, we have demonstrated that the intracellular domain of 5-HT 3A receptors (5-HT 3A -ICD) is required for receptor modulation by RIC-3 because the removal of the ICD eliminated the inhibitory effects of RIC-3 co-expression on 5-HT 3A functional surface expression in X. laevis oocytes [21] .
Further, we designed a chimera in which we added the 5-HT 3A -ICD of 115 amino acids to the prokaryotic homologue of 5-HT 3A , the Gloeobacter violaceus ligand-gated ion channel (GLIC), to substitute the receptor's heptapeptide linker between M3 and M4 transmembrane helices. This addition lead to the observation of modulatory effects on expression of GLIC-5-HT 3A -ICD chimera when co-expressed with RIC-3 while wild type GLIC was insensitive to co-expression [22, 23] . Additionally, we demonstrated that the interaction between GLIC-5-HT 3A -ICD and RIC-3 is direct and does not require the presence of additional proteins. Both proteins were overexpressed in and purified from Escherichia coli (E. coli) and were subjected to a pull-down assay through which we observed an interaction between the two proteins [24] . Subsequently, in a separate study we examined if the 5-HT 3A -ICD alone is sufficient to retain an interaction with RIC-3. We used a chimera obtained by fusing the 5-HT 3A -ICD to the C-terminus of maltose binding protein (MBP). Addition of MBP to the 5-HT 3A -ICD, facilitated the expression, purification and stability of this domain. We determined, using a similar pull down assay, that the purified 5-HT 3A -ICD maintains an interaction with RIC-3 [25] .
In summary, from previous studies, it is known that the 5-HT 3A -ICD is required and sufficient for interaction of the 5-HT 3A R and RIC-3. Furthermore, this direct interaction between the ICD and RIC-3 does not require the presence of other host cell proteins [21] [22] [23] [24] [25] . In the current study, we aimed to identify the segment of the ICD responsible for this interaction with the hypothesis that the interaction site lies within an independent segment of the ICD. In 2014, the X-ray structure of the mouse 5-HT 3A R was published. The complete ECD and TMD were resolved, while part of the ICD (62 amino acids) was missing due to trypsin treatment of the receptor prior to crystallization. This unresolved segment of the ICD, here named L2, is located between the MXhelix that follows a short post M3 loop (L1), and the MA-helix that continues into M4 [26] .
Recently, structures of full-length 5-HT 3A R obtained by single-particle cryo-electron microscopy have been published, however, almost the entirety of the L2 segment remained unresolved [27, 28] . For the purpose of this study, we used the X-ray structure as a guide to design our constructs. Here, we utilized a process of elimination by dividing the ICD into its known structural elements (L1-MX, L2, and MA) ( Figure 1 ), and determined whether RIC-3 interacted with the different segments. Through our experiments we demonstrate that the L1-MX region within the 5-HT 3A -ICD interacts with RIC-3. Our results identified a stretch of 24 amino acids within the 115 amino acid long 5-HT 3A -ICD as the interaction site of RIC-3. fused to the C-terminus of maltose binding protein (MBP) in pMALX vector (New England Biolabs), MBP-5-HT 3A -ICD-pMALX, was used as the template to design constructs for the present study [25, 29] . The fusion constructs were generated by deletion of amino acids from [24, 31, 32] . The MBP-RIC-3-His 6 -pMAL-c2x and hRIC-3-pHEMH19 were used in pull-down and in-vivo interaction assays, respectively.
Materials and Methods

A. Materials
B.3.For in-vivo interaction assays the 5-HT 3A subunit containing the V5 epitope tag (GKPIPNPLLGLDSTQ) close to the N-terminus, and the 5-HT 3B subunit were engineered into the expression vector pGEMHE and were used for full receptor expression in oocytes [21] .
These cDNAs along with cDNA of hRIC-3-pHEMH19 were linearized with the restriction enzyme NheI (New England Biolabs). Subsequently, cRNA of each construct was prepared using T7
RNA polymerase (mMESSAGE mMACHINE ® T7 Kit; Applied Biosystems/Ambion, Austin, TX) in an in-vitro transcription process. The cRNAs were then purified and precipitated with MEGAclear ™ kit (Applied Biosystems/Ambion, Austin, TX) and dissolved in nuclease-free water.
C. Oocytes
Fresh oocytes used in in-vivo interaction assays were harvested from Xenopus laevis frogs and defolliculated in house. Maintenance and surgery procedures were approved by the TTUHSC animal welfare committee. Prior to injection with an automatic oocyte injector (Nanoject II™;
Drummond Scientific Co., Broomall, PA) the oocytes were washed using Ringer's buffer (OR2: 82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH 7.5 ). Injected oocytes were maintained in standard oocyte saline medium (SOS: 100 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 5 mM HEPES, pH 7.5) supplemented with a 1% antibiotic-antimycotic (100x) and 5% horse serum at 15°C. 
D. Protein expression and purification
E. Size exclusion chromatography
The 
F. Pull-down assay
In this assay, 0.05% DDM and 1X protease inhibitor cocktail (Research Products International)
were added to all buffers just before use in each step. 
) and mixtures were incubated at 4°C for 2 hours. 
G. In-vivo interaction assay
The in-vivo interaction assay was designed to probe the interaction of 5-HT 3A 
H. Statistics
Statistical significance was determined with one-way ANOVA and Tukey's multiple comparisons test (**** denotes p < 0.001) of oocytes injected with 5-HT 3A or 5-HT 3AB and RIC-3 vs 5-HT 3A or 5-HT 3AB alone (Prism 6, GraphPad Software, Inc.).
I. SDS-PAGE
For SDS-electrophoresis, 4-15% precast gradient TGX Stain-Free TM gels (Bio-Rad Laboratories) were used and visualized by stain-free enabled imager (Gel Doc TM EZ Imager, Bio-Rad).
Results
In order to further investigate the interaction between the 5-HT 3A R and RIC-3 and determine the interaction site within the 5-HT 3A -ICD, we designed a series of complementary deletion constructs of the 5-HT 3A -ICD in a stepwise manner ( Figure 1 ). Initially, we engineered two deletion constructs based on structural elements observed within the 5-HT 3A -ICD in the crystal structure of the mouse 5-HT 3A receptor [26] . We hypothesized that the interaction with RIC-3 involves specific and likely independent segments of the 5-HT 3A -ICD. The crystal structure of the 5-HT 3A contains a partially resolved ICD with three distinct segments: the MX-helix following a Figure 3A) . The direct interaction of the full-length ICD and RIC-3 had been shown previously in a similar experiment and the ICD construct here was used as a control [25] . MBP alone or omitting the RIC-3 in the pull-down did not reveal the presence of the prey protein.
Eliminating the MA-helix from potential interaction sites of the ICD with RIC-3 shifted our focus to Δ MA which contains L1, MX, and the structurally unresolved L2 segments. We designed three constructs to understand the role of L2, the disordered flexible region between MA-and MX-helices, in the observed interaction between RIC-3 and consistent with the calculated weights of the prey proteins (Table 1 ). Of note, we observed an increase in intensity of these prey bands as the number of deleted amino acids increased. The L2 region of the ICD is formed by 60 amino acids, and by deleting 55 amino acids in Δ 55 construct, we eliminated most of this region from the ICD. Therefore, we hypothesized that the interaction site must lie within the remaining segment of Δ MA; the L1-MX region.
Identifying the short peptide responsible for RIC-3 interaction.
We continued our studies following our initial strategy of stepwise complimentary deletion of amino acids. Our final constructs where designed by using Δ MA as the template. We deleted the L2 region from Δ MA to create the L1-MX construct and, to complement this construct, we deleted the L1-MX segment to create the L2 construct. These constructs were designed to confirm that the L2 region does not confer the interaction of 5-HT 3A and RIC-3 and that L1-MX is independently responsible for mediating this interaction. We performed the RIC-3 pull-down assay and observed a second band corresponding to the size of L1-MX (42 kDa) and no significant band in case of the L2 construct ( Figure 3B ).
In-vivo assay comparing interaction of homomeric and heteromeric 5-HT 3 receptors with
RIC-3.
A sequential alignment between 5-HT 3A and 5-HT 3B subunits of 5-HT 3 receptors revealed that 5-HT 3B potentially lacks the helical structure post M3, the MX-helix ( Figure 4A ). Since we had just demonstrated that the MX-helix mediates the RIC-3 modulation of 5-HT 3A subunits, we wanted to determine whether RIC-3 co-expression impacts functional heteromeric 5-HT3 AB expression similar to homomeric 5-HT 3A expression. 5-HT 3B subunits alone are unable to form functional channels. Co-expression of 5-HT 3A with 5-HT 3B is required for functional expression [34] . We used the cRNA of 5-HT 3A and 5-HT 3B subunits to express homomeric 5-HT 3A 
Discussion
With more than 40 different subunits of the pLGIC super family found in humans, there is a great abundance of these ion channels in neuronal tissues and some expression in nonneuronal cells and tissues [13] . The role of pLGICs is extremely important in signaling mechanisms and functioning of the nervous system, and disruptions to their function lead to a wide variety of diseases and disorders [9] [10] [11] 13] . According to existing structures of several pLGICs, such as 5-HT 3 , several nAChRs, GABA A β 3 and Glyα1 receptors, there is a high conservation in composition and structure of the ECD and TMD of these receptors [26-28, [35] [36] [37] [38] . The commonality of most of these structures is that intracellular domains (ICD) have been removed, shortened, or in case of full-length receptor structures, the ICD remained partially resolved [26, 27] . Additionally, all current drugs targeting these receptors interact with either the ECDs or TMDs [5, 7-9, 39]. Considering the significant sequence similarities of these domains among the super family, drugs interacting with these two conserved domains have been shown to cause undesired side effects by interacting with related subunits. Interestingly, ICDs of these receptors are divers in length, 73 to 262 amino acids in humans, and amino acid composition.
This indicates that targeting the ICD may yield subtype-specific drugs. Therefore, the ICDs may represent safer and more effective potential drug targets for many diseases and disorders [8, 40] . Resistance to inhibitors of cholinesterase (RIC-3) is a chaperon protein known to modulate maturation and membrane trafficking of some members of pLGICs. Previously we have shown that the ICD mediates this interaction [21] [22] [23] ,and that the ICD alone, in the absence of both ECD and TMD, interacts with RIC-3 [25] .
In the present study, we aimed to identify the segment of the ICD involved in the interaction with RIC-3 using a series of constructs that were designed with different deletions of segments of the Furthermore, a direct correlation between intensity of the interaction (observed by intensity of the corresponding band on the gel) and the number of amino acids deleted from the L2 region was observed. We suspect that the deletion of amino acids from the L2 region caused conformational changes that facilitated interaction between ICD and RIC-3. Consequently, we inferred that neither the MA-helix nor L2 are the primary contributor to interaction sites of the ICD with RIC-3. At this point we hypothesized that the L1-MX region contains the interacting segment. From the crystal structure of the 5-HT 3A it is possible to infer that the MX-helix would be responsible for mediating the interaction between the 5-HT 3A receptor and a membrane protein such as RIC-3. The conformation of the MX-helix in the structure and positional proximity of this helix to the membrane spanning helices creates a favorable position for proteinprotein interaction. One caveat was mentioned in the paper: "However, whether the conformation of the post-M3 loop and of the MX helix in the detergent-solubilized, trypsintreated, crystallized receptors do accurately represent a physiological conformation of intact receptors at the plasma membrane remains to be investigated" [26] . To assess our hypothesis, we designed two constructs, L1-MX and L2. The observed interaction between the L1-MX but not the L2 construct and RIC-3 indicated our hypothesis to be true. In conclusion, we have identified the 24 amino acid long L1-MX segment of the ICD to be the interaction site of the 5-HT 3A receptor and RIC-3.
As mentioned previously, chaperon protein RIC-3 has been shown to be a modulator of functional surface expression of 5-HT 3A Rs, the only homomeric receptors in 5-HT 3 . In this study, we have identified the L1-MX segment of the 5-HT 3A subunit to be responsible for interaction between 5-HT 3A Rs and RIC-3. Interestingly, according to a canonical sequence alignment between 5-HT 3A and 5-HT 3B subunits and secondary structure predictions using PSIPRED the 5-HT 3B lacks the MX-helix ( Figure 5 ). Here, we investigated the effect of RIC-3 on heteromeric 5-HT3 AB Rs to widen our understanding of these highly native-like receptors. We coexpressed the mRNA of both 5-HT3 A and 5-HT3 AB with hRIC-3 in X. oocytes and recorded the currents in response to 5-HT using TEVC. Co-expression of RIC-3 attenuated 5-HT-induced currents in both 5-HT 3A and 5-HT 3AB expressing oocytes, with no significant difference between 5-HT 3A Rs and 5-HT 3AB Rs. It has been suggested that heteromerization of 5-HT 3B subunits with 5-HT 3A subunits covers ER-retention signals found in 5-HT 3B subunits [44] . Our results, although not conclusive, suggest different possibilities leading to hRIC-3 attenuating surface expression of 5-HT3 AB : RIC-3 may bind to unassembled 5-HT 3A subunits and inhibit their assembly with 5-HT 3A or 5-HT 3B subunits and thus inhibit both homomer and heteromer formation, or the interaction may block trafficking to the membrane.
Several lines of evidence, including a point mutation in the 5-HT 3A -ICD , support the involvement . In the present study, we used a series of deletions and a direct protein-protein interaction assay to more closely define the interaction site of RIC-3 within the 5-HT 3A -ICD. We identified a 24 amino acid long peptide, L1-MX, to bear the interaction site.
Further studies are needed to identify the face of the α -helix or the exact amino acids responsible for this interaction and additionally to delineate the binding site on RIC-3. Our data provides a potential surface area for future drug design to specifically target 5-HT 3 receptors and creates the basis for novel approaches for the treatment of these diseases.
Acknowledgments
Research reported in this publication was supported by the National Institute of Neurological 
